Connect your AI

Dianthus Therapeutics DNTH Total Assets

Total Assets at other companies

Johnson & JohnsonJNJ

$200.89B+3.7%

AmgenAMGN

$92.5B+3.5%

Spyre Therapeutics, Inc.SYRE

$763.95M+34.1%

Kymera TherapeuticsKYMR

$1.67B+81.7%

Protagonist TherapeuticsPTGX

$697.46M-6.0%

TG TherapeuticsTGTX

$1.53B+133%

Other financials

Income statement

Revenue$396.0K-81.8%

Operating income-$46.5M-40.3%

Net income-$40.8M-38.4%

EPS (diluted)-$0.85-3.7%

Balance sheet

Cash & equivalents$627.7M+6,105%

Total debt$1.4M-2.3%

Total equity$1.2B+266%

Cash flow

Operating cash flow-$28.9M-4.4%

CapEx$10.0K-58.3%

Free cash flow-$28.9M-4.4%

Valuation

Market cap$4.51B+662%

Enterprise value$3.88B+565%

P/S1,465.1×+962×

Profitability

Operating margin-4,558.4%-9,354pp

Net margin-4,104.8%-7,304pp

FCF margin-3,561.6%-6,956pp

Returns & leverage

Return on equity-28.6%+3.2pp

Debt / equity0×0.0×

Current ratio29.3×+13.3×

Where this comes from

Reported directly by Dianthus Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: Dianthus Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Dianthus Therapeutics's total assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Dianthus Therapeutics's total assets?: Dianthus Therapeutics (DNTH) reported total assets of $1.25B in Q1 2026.
How has Dianthus Therapeutics's total assets changed year-over-year?: Dianthus Therapeutics's total assets increased by 257.7% year-over-year, from $348.58M to $1.25B.
What is the long-term trend for Dianthus Therapeutics's total assets?: Over 5 years (2020 to 2025), Dianthus Therapeutics's total assets has grown at a 26.9% compound annual growth rate (CAGR), from $161.62M to $530.92M.
What does total assets mean?: The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.